http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2727695-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9e6dea4e4a097e88c42a7a08582bf25
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-24
filingDate 2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02a25ed8d04fc321aaad135c030068f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07731cf6f2e32f388d76851fbefb5b26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68eb43b0541e7c697aedfae3d556eba6
publicationDate 2020-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2727695-C1
titleOfInvention Method of complex treatment of rhinophyma
abstract FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to otorhinolaryngology, and can be used for complex treatment of rhinophyma. That is ensured by removing the rhinophymatics masses by an electrode from the cold plasma surgery apparatus in the "coblation" device operation mode. That is followed by layer-by-layer decortication of the altered skin to achieve an anatomically correct shape of the nose. During surgical intervention, skin is preserved on intact nostril inner surface. In the postoperative period, on the following postoperative day, the patient is exposed to the postoperative wound exogenous nitrogen oxide (NO) daily using the NO-therapy apparatus and plasma surgery in the maximum mode for 60–200 seconds for 5 days. n EFFECT: method enables higher clinical effectiveness of rhinophyma ensured by complex action, avoiding infection of wound, pain syndrome, rough cicatrical deformations of soft tissues of nose with good cosmetic effect and reduction of length of stay in hospital. n 1 cl, 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2791386-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2802998-C1
priorityDate 2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2400164-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501462

Total number of triples: 23.